¶ DNA Damage Response and Repair in Neurodegeneration
Dna Damage Response And Repair In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The DNA damage response (DDR) is a critical cellular mechanism that maintains genomic integrity. Accumulating evidence links impaired DNA repair to aging and neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (FTD), and Huntington's disease (HD)[1].
Neurons are particularly vulnerable to DNA damage due to:
- High metabolic rate and oxidative stress
- Post-mitotic state (cannot dilute damage through cell division)
- Long lifespan requiring decades of genomic maintenance
- High neuronal activity increasing ROS production
- Oxidative damage: 8-oxoguanine (8-oxoG) lesions from reactive oxygen species
- Single-strand breaks (SSBs): Abasic sites, alkylation damage
- Double-strand breaks (DSBs): Most cytotoxic, from replication stress or ROS
- UV radiation: Cyclobutane pyrimidine dimers (in skin, not brain)
- Ionizing radiation: DSBs
- Environmental toxins: MPTP, 6-OHDA, pesticides
Primary pathway for oxidative damage
- Glycosylases: OGG1 (8-oxoG), NTH1, MYH
- AP endonuclease: APE1
- DNA polymerase: Polβ
- Ligase: LIG3/XRCC1
In neurodegeneration:
- OGG1 activity declines with age
- OGG1 polymorphisms associated with PD risk[2]
Bulky lesions, UV damage
- Global genome NER (GG-NER): XPC, CSA, CSB
- Transcription-coupled NER (TC-NER): CSA, CSB, XPG
In neurodegeneration:
- CSB mutations cause Cockayne syndrome
- TC-NER defects linked to Alzheimer's
Replication errors, small loops
- Key proteins: MSH2, MSH6, MLH1, PMS2
In neurodegeneration:
- MMR defects in Huntington's disease
- Somatic CAG repeat expansions in HD
¶ Double-Strand Break Repair
- RAD51 filament formation
- BRCA1/2 involvement
- Resolution: RAD51, XRCC2/3
- Ku70/Ku80 binding
- DNA-PKcs activation
- Ligation: XRCC4, LIG4
In neurodegeneration:
- ATM mutations cause ataxia-telangiectasia
- NBS1 mutations linked to neurodegeneration
| Protein |
Function |
Disease Association |
| ATM |
DSB sensing, cell cycle arrest |
Ataxia-telangiectasia, PD risk |
| ATR |
Replication stress response |
ALS, HD |
| PARP1 |
SSB repair, DNA damage signaling |
PD, AD |
| OGG1 |
BER glycosylase for 8-oxoG |
PD, aging |
| TDP-43 |
RNA/DNA binding, DNA repair |
ALS, FTD |
| FUS |
RNA processing, DNA repair |
ALS, FTD |
| C9orf72 |
DNA damage response |
ALS/FTD |
- Oxidative stress: Increased 8-oxoG in AD brain
- BER impairment: Reduced OGG1, Polβ activity
- Neuronal vulnerability: Accumulation of DNA lesions
- Therapeutic targets: PARP inhibitors, BER enhancers[3]
- Environmental toxins: MPTP, 6-OHDA cause DSBs
- Mitochondrial DNA: mtDNA mutations accumulate
- NRF2 connection: Oxidative stress and DNA damage intersect
- ATM activation: PINK1/Parkin regulate ATM signaling
- C9orf72: DSB repair dysfunction
- TDP-43: Implicated in DNA repair
- FUS: DNA damage response role
- PARylation: Altered in ALS models
- CAG repeat instability: Somatic expansions
- DNA repair gene variants: Modify age of onset
- BER dysfunction: Mutant huntingtin impairs repair
- Oxidative lesions: Accumulation in striatum
flowchart TD
subgraph Sensing
SSB[Single-Strand Break] --> PARP1
DSB[Double-Strand Break] --> ATM
ROS[Oxidative Damage] --> OGG1
end
subgraph Signaling
PARP1 --> NAD[NAD+ Depletion] -->
ATM --> p53[p53 Activation] -->
NAD --> SIRT1[SIRT1 Dysfunction]
end
subgraph Outcomes
p53 --> Apoptosis
SIRT1 --> Metabolic Dysfunction
Apoptosis --> Neuronal Death
end
- Olaparib, Rucaparib: FDA-approved for cancer
- Neuroprotective effects in PD models
- Challenges: May interfere with DNA repair in dividing cells
- Polβ activators: Enhance repair capacity
- OGG1 modulators: Increase 8-oxoG repair
- Nicotinamide riboside (NR)
- Nicotinamide mononucleotide (NMN)
- Restore PARP/SIRT1 balance
- CoQ10: Mitochondrial DNA protection
- MitoQ: Targeted mitochondrial antioxidant
The study of Dna Damage Response And Repair In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
[1] Madabhushi R, Pan L, Tsai LH. DNA damage and its links to neurodegeneration. Neuron. 2014;83(2):266-282. DOI
-
[2] Fukushima T, et al. Association between OGG1 Ser326Cys polymorphism and Parkinson's disease. Arch Neurol. 2008;65(4):519-524. DOI
-
[3] Strosznajder JB, et al. Poly(ADP-ribose) polymerase-1 in DNA damage response and neurodegeneration. J Neurochem. 2012;123(2):180-191. DOI
-
[4] Katyal S, et al. DNA damage signaling in neurons. Nat Rev Neurosci. 2014;15(2):105-119. DOI
-
[5] Guo Z, et al. DNA repair in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2018;89(10):e53. DOI
-
[6] Huber A, et al. TDP-43 and DNA damage in ALS. Brain. 2020;143(7):2042-2054. DOI
-
[7] Couve A, et al. DNA repair in Huntington's disease. J Huntingtons Dis. 2021;10(1):1-15. DOI
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
7 references |
| Replication |
33% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 32%